Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Adobe Recertifies Two Products for Pharma Use

By Drug Discovery Trends Editor | June 24, 2009

SAFE-BioPharma Association announced from the 45th Annual Drug Information Association (DIA) Meeting that Adobe Systems Incorporated has recertified two software products used extensively in the pharmaceutical industry. The products — Adobe Acrobat and Adobe Reader with Adobe LiveCycle Reader Extensions ES — were found to be fully compliant with the SAFE-BioPharma industry standard. The products were initially certified by SAFE-BioPharma two years ago and were recertified in 2008, along with Adobe LiveCycle Digital Signatures ES, which remains fully compliant with the SAFE-BioPharma standard.

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma digital identity and signature standard for the pharmaceutical and healthcare industries.

“As the top pharmaceutical companies continue to recognize the numerous advantages of adopting the SAFE-BioPharma standard and Adobe life sciences solutions, it is crucial that Adobe products remain compliant with the standard,” said Melonie Warfel, director of worldwide standards and life sciences at Adobe. “Adobe and SAFE-BioPharma remain committed to helping life sciences organizations embrace technology to work faster and smarter.”

The SAFE-BioPharma digital identity and signature standard is designed and used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It provides users with a secure, enforceable and regulatory-compliant way to verify identities of parties involved in electronic transactions and to apply their digital signatures to electronic documents. By using SAFE-BioPharma digital signatures, companies are able to dispense with paper originals and other cumbersome forms of backup.

“Adobe continues to play an important role in enabling pharmaceutical companies to bring better drugs to market faster and cheaper,” said Mollie Shields-Uehling, president and chief executive officer, SAFE-BioPharma Association. “By recertifying these important digital identity and workflow solutions, Adobe shows its continued dedication to streamlining and securing pharmaceutical processes.”

Adobe recertifies its products primarily used in the pharmaceutical industry through an inexpensive self-certification process introduced by SAFE-BioPharma.

Adobe Acrobat and Adobe Reader software enable biopharmaceutical and other professionals to reliably create, combine, and control Adobe PDF documents for easy, more secure distribution, collaboration, and data collection. Adobe LiveCycle solutions help accelerate the flow of information between people, documents, and enterprise processes while providing more control over sensitive information. Mixing the best of print and electronic communications, LiveCycle ES leverages the ubiquity of Adobe Flash and Reader to ensure that almost anyone can engage with information.

SAFE-BioPharma


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE